AEPCX
Price
$62.33
Change
-$0.26 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.72B
HNCUX
Price
$22.49
Change
+$0.04 (+0.18%)
Updated
Oct 17 closing price
Net Assets
368.15M
Interact to see
Advertisement

AEPCX vs HNCUX

Header iconAEPCX vs HNCUX Comparison
Open Charts AEPCX vs HNCUXBanner chart's image
American Funds EUPAC C
Price$62.33
Change-$0.26 (-0.42%)
VolumeN/A
Net Assets137.72B
Hartford International Growth R6
Price$22.49
Change+$0.04 (+0.18%)
VolumeN/A
Net Assets368.15M
AEPCX vs HNCUX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. HNCUX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and HNCUX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 138B vs. HNCUX (368M). HNCUX pays higher dividends than AEPCX: HNCUX (0.39) vs AEPCX (0.16). AEPCX was incepted earlier than HNCUX: AEPCX (25 years) vs HNCUX (8 years). AEPCX (1.57) is less costly to investors than HNCUX (0.89). AEPCX is a more actively managed with annual turnover of: 35.00 vs. HNCUX (31.00). HNCUX has a lower initial minimum investment than AEPCX: HNCUX (0) vs AEPCX (250). HNCUX annual gain was more profitable for investors over the last year : 23.69 vs. AEPCX (10.02). HNCUX return over 5 years is better than : 31.20 vs. AEPCX (9.92).
AEPCXHNCUXAEPCX / HNCUX
Total Expense Ratio1.570.85185%
Annual Report Gross Expense Ratio1.570.89176%
Fund Existence25 years8 years-
Gain YTD20.63126.27779%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets138B368M37,500%
Annual Yield % from dividends0.160.3940%
Returns for 1 year10.0223.6942%
Returns for 3 years45.8586.2453%
Returns for 5 years9.9231.2032%
Returns for 10 years36.76N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIGI157.623.03
+1.96%
Colliers International Group
NTRSO20.000.04
+0.20%
Northern Trust Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp